YEAR-ROUND GENOMIC DATA SECURITY AND REGULATORY COMPLIANCE IN RUSSIA

1. INTRODUCTION

Year-round genomic data security in Russia concerns the continuous protection, storage, processing, transmission and controlled disclosure of genetic information throughout the entire data lifecycle. Genomic information includes DNA sequences, genetic test results, hereditary disease information, biological identification records and other information capable of revealing an individual's genetic characteristics.

Genomic data is particularly sensitive because it can disclose information not only about an individual but also about biological relatives. Unauthorised disclosure may create risks involving discrimination, identity misuse, privacy violations and unauthorised commercial exploitation.

Russia does not have a separate comprehensive statute exclusively regulating genomic data security throughout the year. Instead, genomic information is protected through general personal data legislation, medical confidentiality requirements, genetic research regulations and information-security laws.

2. PRINCIPAL LEGISLATIVE FRAMEWORK

A. Federal Law No. 152-FZ of 27 July 2006 on Personal Data

This is the principal legislation governing personal data processing in Russia.

Article 5 establishes principles of lawful, fair and purpose-limited processing.

Article 6 regulates the legal grounds for processing personal information.

Article 10 provides additional protection for special categories of personal data, including health-related information.

Article 18.1 establishes obligations concerning personal data processing policies and organisational safeguards.

Article 19 requires operators to implement legal, organisational and technical measures to protect personal data against unlawful or accidental access, destruction, modification, blocking, copying and dissemination.

Genomic information linked to an identifiable person may therefore require enhanced protection as personal data and, depending on its content, as health-related sensitive information.

B. Federal Law No. 323-FZ of 21 November 2011 on the Fundamentals of Health Protection

This legislation establishes patient rights and medical confidentiality requirements.

Article 13 protects information constituting medical confidentiality, including information concerning medical examinations, diagnoses and treatment.

Genetic test results maintained by medical institutions may fall within these confidentiality protections.

C. Federal Law No. 149-FZ of 27 July 2006 on Information, Information Technologies and Information Protection

This law establishes general requirements for information protection, access control and information-system security.

It is relevant to genomic databases, sequencing laboratories, electronic medical records and genomic research platforms.

D. Federal Law No. 242-FZ of 21 July 2014

This legislation introduced important amendments concerning the localisation of personal data.

Under Article 18(5) of Federal Law No. 152-FZ, applicable personal data operators must comply with Russian database localisation requirements when collecting personal data of Russian citizens through the internet, subject to statutory exceptions.

Genomic databases must therefore assess localisation obligations before transferring or storing relevant information abroad.

E. Federal Law No. 180-FZ of 23 June 2016 on Biomedical Cell Products

This legislation may become relevant when genomic information is processed in connection with biomedical cell product development, manufacturing and clinical applications.

3. YEAR-ROUND GENOMIC DATA-SECURITY REQUIREMENTS

Year-round compliance requires continuous safeguards rather than a single annual security audit.

A. Data Collection and Consent

Genomic information must be collected on an appropriate legal basis. Where consent is required, it should clearly identify the purpose of collection, categories of information, processing activities and applicable disclosure arrangements.

B. Encryption and Secure Storage

Genomic databases should implement appropriate encryption, secure authentication, access restrictions and backup arrangements.

C. Access-Control Requirements

Hospitals, laboratories and research organisations should adopt role-based access controls. Only authorised personnel should access identifiable genomic records for legitimate purposes.

D. Data Retention and Deletion

Personal data must not be retained indefinitely without an applicable legal basis. Retention periods should reflect the processing purpose and statutory requirements.

E. International Data Transfers

Transfers of genomic information outside Russia must comply with Article 12 of Federal Law No. 152-FZ, including applicable notification and foreign-recipient assessment requirements.

F. Security Incident Management

Organisations must establish procedures for detecting, documenting and responding to genomic data breaches.

Under Article 21 of Federal Law No. 152-FZ, operators have statutory notification obligations concerning personal data incidents, including initial notification to Roskomnadzor within 24 hours and investigation results within 72 hours, subject to applicable legal requirements.

4. CONTINUOUS COMPLIANCE AND SECURITY AUDITS

A year-round compliance programme should include the following activities:

Daily monitoring of database access and suspicious activity.

Regular review of employee permissions.

Periodic vulnerability assessments.

Continuous encryption and backup verification.

Quarterly reviews of genomic research access permissions.

Periodic employee confidentiality training.

Annual comprehensive cybersecurity and compliance audits.

Immediate investigation of suspected unauthorised disclosures.

Regular review of international data-sharing agreements.

Documentation of data-retention and deletion decisions.

These are recommended governance measures. The precise frequency of mandatory audits depends on the applicable legal and technical requirements.

5. RELEVANT CASE LAWS AND JUDICIAL AUTHORITIES

Russian courts have not developed an extensive body of reported judgments specifically concerning genomic database cybersecurity. The following authorities provide relevant direct statutory interpretations or analogous privacy principles.

1. Roman Zakharov v. Russia (2015) — Analogous authority.

The European Court of Human Rights examined secret surveillance and safeguards against abuse. The judgment emphasised the need for effective legal protections where personal information is collected and accessed by authorities.

Its principles are relevant to government access to genomic databases.

2. S. and Marper v. United Kingdom (2008) — Analogous authority.

The European Court considered the retention of DNA profiles and biological samples by law-enforcement authorities. It recognised the sensitive character of genetic information and the privacy implications of indefinite retention.

This is particularly relevant to genomic database retention policies.

3. Gaskin v. United Kingdom (1989) — Analogous authority.

The Court examined access to personal records and the importance of safeguards surrounding sensitive personal information. Its reasoning is relevant to individual access rights concerning genomic records.

4. Z v. Finland (1997) — Analogous authority.

The Court emphasised the importance of confidentiality in medical information. It recognised that protecting health information is essential to preserving confidence in medical services.

This principle is particularly relevant to hospitals and genetic testing laboratories.

5. I v. Finland (2008) — Analogous authority.

The Court considered inadequate protection of confidential medical records and the absence of effective safeguards against unauthorised access. The judgment provides important guidance for electronic genomic record systems.

6. Biriuk v. Lithuania (2008) — Analogous authority.

The Court examined the disclosure of highly sensitive medical information and recognised the importance of protecting medical privacy. Its reasoning is relevant to unauthorised disclosure of genetic test results.

These judgments are comparative European human-rights authorities rather than direct Russian genomic cybersecurity precedents. Their application must also account for Russia's cessation of membership in the European Convention on Human Rights in September 2022.

6. LIABILITY FOR GENOMIC DATA-SECURITY VIOLATIONS

A. Administrative Liability

Article 13.11 of the Russian Code of Administrative Offences provides administrative penalties for violations of personal data processing requirements.

Additional liability may arise from violations of applicable information-security and confidentiality obligations.

B. Criminal Liability

Article 137 of the Russian Criminal Code addresses violations of privacy, including unlawful collection or dissemination of information concerning private life.

Article 272 addresses unlawful access to computer information where its statutory elements are satisfied.

C. Civil Liability

Article 24 of Federal Law No. 152-FZ and applicable Civil Code provisions provide legal mechanisms for addressing harm resulting from unlawful personal data processing.

D. Regulatory Enforcement

Roskomnadzor supervises compliance with personal data legislation. Other competent authorities may exercise oversight depending on the nature of the organisation and information system.

7. PRACTICAL COMPLIANCE REQUIREMENTS FOR GENOMIC INSTITUTIONS

Russian hospitals, biotechnology companies, genomic laboratories and research organisations should:

Maintain a documented genomic data inventory.

Classify genetic and health-related information appropriately.

Establish lawful processing grounds.

Implement encryption and access restrictions.

Maintain secure audit logs.

Conduct regular security assessments.

Establish incident-response procedures.

Comply with applicable Russian data localisation requirements.

Review international research-sharing arrangements.

Maintain legally compliant retention and deletion policies.

Train employees in medical confidentiality and cybersecurity.

Ensure accountability for third-party data processors.

8. FUTURE REGULATORY DEVELOPMENTS

Russia would benefit from a dedicated genomic data-security framework addressing the unique characteristics of hereditary information.

Future reforms could establish specialised genomic-data classifications, stronger restrictions on secondary use, mandatory genetic database security standards, clear rules for familial genetic information and enhanced protections against genetic discrimination.

Artificial intelligence-based genomic analysis should also receive attention because automated systems may infer sensitive hereditary characteristics from apparently anonymised datasets.

9. CONCLUSION

Year-round genomic data security in Russia depends on the continuous implementation of personal data protection, medical confidentiality, information security and cybersecurity obligations.

Federal Laws No. 152-FZ, No. 323-FZ and No. 149-FZ form the principal legal foundation for protecting identifiable genomic information. Their requirements extend beyond initial consent and collection to storage, access, international transfers, security incidents and lawful retention.

Although Russian judicial precedent specifically addressing genomic database breaches remains limited, comparative decisions concerning DNA retention, medical confidentiality and electronic health records provide important interpretative guidance. Effective year-round compliance requires continuous monitoring, technical safeguards, organisational accountability and protection of individual genetic privacy.